BIOCURE TECHNOLOGY INC. Total Liabilities

Latest as of December 2025: €435.01K EUR ≈ $508.58K USD

BIOCURE TECHNOLOGY INC. total liabilities. Based on the latest financial reports, BIOCURE TECHNOLOGY INC. (1WH) has total liabilities worth €435.01K EUR (≈ $508.58K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 1WH defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Total Liabilities of BIOCURE TECHNOLOGY INC. (2021–2025)

Total liabilities of BIOCURE TECHNOLOGY INC. from 2021 to 2025. This chart illustrates how BIOCURE TECHNOLOGY INC.'s total liabilities have evolved over time, based on quarterly financial data. See BIOCURE TECHNOLOGY INC. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

BIOCURE TECHNOLOGY INC. Competitors by Total Liabilities

The table below lists competitors of BIOCURE TECHNOLOGY INC. ranked by their total liabilities.

Company	Country	Total Liabilities
James Cropper PLC LSE:CRPR	UK	GBX52.55 Million
International Frontier Resources Corporation V:IFR	Canada	CA$2.68 Million
Li Bang International Corporation Inc. Ordinary Shares NASDAQ:LBGJ	USA	$23.59 Million
Rare Foods Australia Ltd AU:RFA	Australia	AU$6.01 Million
Lifeist Wellness Inc V:LFST	Canada	CA$708.54K
Marwyn Value Investors Limited LSE:MVI	UK	GBX143.50K
Identillect Technologies Corp V:ID	Canada	CA$1.75 Million
Tearlach Resources Ltd V:TEA	Canada	CA$1.02 Million

Liability Composition Analysis (2021–2025)

This chart breaks down BIOCURE TECHNOLOGY INC.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BIOCURE TECHNOLOGY INC. total assets.

Liquidity & Leverage Metrics

BIOCURE TECHNOLOGY INC. Total Liabilities Ratios Explained

BIOCURE TECHNOLOGY INC. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.10	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BIOCURE TECHNOLOGY INC.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BIOCURE TECHNOLOGY INC. (2021–2025)

The table below shows the annual total liabilities of BIOCURE TECHNOLOGY INC. from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€435.01K ≈ $508.58K	-33.13%
2024-12-31	€650.57K ≈ $760.59K	+74.30%
2023-12-31	€373.24K ≈ $436.36K	-91.54%
2022-12-31	€4.41 Million ≈ $5.16 Million	-11.87%
2021-12-31	€5.01 Million ≈ $5.85 Million	--

About BIOCURE TECHNOLOGY INC.

F:1WH Germany Biotechnology

Market Cap

$2.80 Million

€2.40 Million EUR

Market Cap Rank

#30717 Global

#2683 in Germany

Share Price

€0.03

Change (1 day)

+21.43%

52-Week Range

€0.02 - €0.03

All Time High

€1.65